October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research on aortic stenosis (AS) was presented by cardiologist Philippe Généreux, MD, Director of the Struct

October 26, 2023 —  Royal Philips, a global leader in health technology, announced the latest results demonstrating the safety of Philips instant w

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive heart devices in treating mitral and tricuspid valve disease.

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care solutions, today announced results from three clinical studies supporting the use

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued a joint statement in response to the new research on aortic valve replacement in low-risk patients announced this week at the Transcatheter Cardiovascular

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in United States’ patients with cardiogenic shock.

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical data from the DESyne BDS Plus Randomized Controlled Trial (RCT) during the Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, in San Francisco, CA.

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years.

October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT), the annual scientific symposium of the Cardiovascular Research Foundation, demonstrating that patients treated for pulmonary embolism (PE) with the Boston Scientific 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now